ID: ALA140972

Max Phase: Preclinical

Molecular Formula: C22H24ClN5O2S

Molecular Weight: 457.99

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc(Cl)cc4)CC3)c2cc1OC

Standard InChI:  InChI=1S/C22H24ClN5O2S/c1-29-19-11-17-18(12-20(19)30-2)25-14-26-21(17)27-7-9-28(10-8-27)22(31)24-13-15-3-5-16(23)6-4-15/h3-6,11-12,14H,7-10,13H2,1-2H3,(H,24,31)

Standard InChI Key:  KVSCJEFMRSEDOZ-UHFFFAOYSA-N

Associated Targets(Human)

Platelet-derived growth factor receptor 507 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 457.99Molecular Weight (Monoisotopic): 457.1339AlogP: 3.91#Rotatable Bonds: 5
Polar Surface Area: 63.08Molecular Species: ZWITTERIONHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.89CX Basic pKa: 13.61CX LogP: 5.23CX LogD: 5.22
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.36Np Likeness Score: -1.08

References

1. Matsuno K, Nakajima T, Ichimura M, Giese NA, Yu JC, Lokker NA, Ushiki J, Ide S, Oda S, Nomoto Y..  (2002)  Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.,  45  (20): [PMID:12238930] [10.1021/jm0201114]

Source